VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹28 Cr | ₹18 Cr | ₹60 Cr | ₹58 Cr | ₹46 Cr |
What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹28 Cr |
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹46 Cr |
How is Total Non-Current Liabilities of VENUS REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹28 Cr | 52.57 | |
| Mar2025 | ₹18 Cr | -69.12 | |
| Mar2024 | ₹60 Cr | 2.89 | |
| Mar2023 | ₹58 Cr | 26.60 | |
| Mar2022 | ₹46 Cr | - | |
Compare Total Non-Current Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,130.7 Cr | -2.6% | -10.3% | 242.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -2.6% |
-10.3% |
242.4% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses